Table 2.
Neoadjuvant therapy | n = 36 |
Clinical response | |
PR | 18 (50) |
SD | 18 (50) |
Mandard grade | |
1 | 3 (8.3) |
2 | 4 (11.1) |
3 | 4 (11.1) |
4 | 3 (8.3) |
5 | 22 (61.1) |
PR: Partial remission; SD: Stable disease.
Neoadjuvant therapy | n = 36 |
Clinical response | |
PR | 18 (50) |
SD | 18 (50) |
Mandard grade | |
1 | 3 (8.3) |
2 | 4 (11.1) |
3 | 4 (11.1) |
4 | 3 (8.3) |
5 | 22 (61.1) |
PR: Partial remission; SD: Stable disease.